Cargando…
Elevated Release of Beta-thromboglobulin and Platelet Factor 4 in Cerebral Infarction Patients with Branch Atheromatous Disease: A Preliminary Report
This study evaluated the levels of the platelet activation markers beta-thromboglobulin (beta-TG) and platelet factor 4 (PF4) in patients with branch atheromatous disease (BAD). Patients with newly diagnosed cerebral infarctions were recruited into the study; those with cardiogenic cerebral infarcti...
Autores principales: | YOKOTE, Akiyoshi, HASHIMOTO, Kazutoshi, BIKEI, Ryu, NAKAMOTO, Hidetoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663031/ https://www.ncbi.nlm.nih.gov/pubmed/26369876 http://dx.doi.org/10.2176/nmc.rc.2015-0042 |
Ejemplares similares
-
Plasma concentrations of the platelet-specific beta-thromboglobulin in malignant disease.
por: Farrell, R. J., et al.
Publicado: (1980) -
Study on the Platelet Factor and β-Thromboglobulin in the Patients with Ischemic Heart Disease
por: Kim, Myung Hwan, et al.
Publicado: (1986) -
Mechanical Endovascular Recanalization in a Patient with Middle Cerebral Artery Occlusion by Tumorous Emboli Originating from Cardiac Myxoma
por: Ryu, Bikei, et al.
Publicado: (2015) -
Branch atheromatous disease and treatment
por: Duan, Honglian, et al.
Publicado: (2022) -
Pathophysiology and Optimal Treatment of Intracranial Branch Atheromatous Disease
por: Deguchi, Ichiro, et al.
Publicado: (2023)